Literature DB >> 20443165

Homology modeling of G-protein-coupled receptors with X-ray structures on the rise.

Talia Yarnitzky1, Anat Levit, Masha Y Niv.   

Abstract

GPCRs are key components of signal transduction pathways and are important drug targets. Recently determined GPCR structures provide opportunities for advancements in GPCR modeling. This review focuses on the choice of experimental templates, the treatment of extracellular loops and the description of ligand-binding sites in GPCR modeling. Four important conclusions are reached in this review: (i) multi-template models may produce better structures than single-template models, although inferior models may also be generated by multi-template approaches, warranting the development and application of improved model assessment methods; (ii) cautious incorporation of knowledge-based constraints can improve the quality of models and docking; (iii) molecular dynamics simulations account for structural features not observed in X-ray structures and may refine docking poses; and (iv) while progress in de novo methods for long loop prediction is ongoing, loopless models provide a practical alternative for docking and virtual screening applications.

Mesh:

Substances:

Year:  2010        PMID: 20443165

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  25 in total

1.  VITAL NMR: using chemical shift derived secondary structure information for a limited set of amino acids to assess homology model accuracy.

Authors:  Michael C Brothers; Anna E Nesbitt; Michael J Hallock; Sanjeewa G Rupasinghe; Ming Tang; Jason Harris; Jerome Baudry; Mary A Schuler; Chad M Rienstra
Journal:  J Biomol NMR       Date:  2011-11-03       Impact factor: 2.835

Review 2.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

3.  G protein-coupled odorant receptors: From sequence to structure.

Authors:  Claire A de March; Soo-Kyung Kim; Serge Antonczak; William A Goddard; Jérôme Golebiowski
Journal:  Protein Sci       Date:  2015-06-22       Impact factor: 6.725

Review 4.  Modeling of mammalian olfactory receptors and docking of odorants.

Authors:  Guillaume Launay; Guenhaël Sanz; Edith Pajot-Augy; Jean-François Gibrat
Journal:  Biophys Rev       Date:  2012-09-01

5.  Comparative Modeling and Evaluation of Leukotriene B4 Receptors for Selective Drug Discovery Towards the Treatment of Inflammatory Diseases.

Authors:  Mahmoud A A Ibrahim; Alaa M A Hassan
Journal:  Protein J       Date:  2018-12       Impact factor: 2.371

Review 6.  The GPCR Network: a large-scale collaboration to determine human GPCR structure and function.

Authors:  Raymond C Stevens; Vadim Cherezov; Vsevolod Katritch; Ruben Abagyan; Peter Kuhn; Hugh Rosen; Kurt Wüthrich
Journal:  Nat Rev Drug Discov       Date:  2012-12-14       Impact factor: 84.694

7.  Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors.

Authors:  Anne Rediger; Carolin L Piechowski; Chun-Xia Yi; Patrick Tarnow; Rainer Strotmann; Annette Grüters; Heiko Krude; Torsten Schöneberg; Matthias H Tschöp; Gunnar Kleinau; Heike Biebermann
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

Review 8.  Allosteric modulation of metabotropic glutamate receptors.

Authors:  Douglas J Sheffler; Karen J Gregory; Jerri M Rook; P Jeffrey Conn
Journal:  Adv Pharmacol       Date:  2011

9.  Benchmarking GPCR homology model template selection in combination with de novo loop generation.

Authors:  Gregory L Szwabowski; Paige N Castleman; Chandler K Sears; Lee H Wink; Judith A Cole; Daniel L Baker; Abby L Parrill
Journal:  J Comput Aided Mol Des       Date:  2020-07-31       Impact factor: 3.686

10.  Probing GPCR structure: adenosine and P2Y nucleotide receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Francesca Deflorian
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.